TPA Partnering
Plan sponsors must report for the 2023 calendar year by June 1st , 2024
Plan sponsors must report for the 2023 calendar year by June 1st , 2024
For those TPAs who have fully explored the new Drug Cost Reporting Requirements, you are likely aware that this effort will require coordination between you (as the TPA) plus the Plan Sponsor and PBM. Specifically, you lack some of the data necessary to complete your portion of the data files. As we consult our TPA clients, this often comes as a surprise.
This creates a precarious situation for TPAs since ultimately if anything falls through the cracks you will likely end up being blamed. The marketplace is under the impression that the PBMs ‘have it all covered‘ since, after all, this is supposed to be Drug Cost reporting. In reality, PBMs have a complex set of questions to consider in determining their optimal strategy and very often will decide not to report on behalf of plan sponsors.
This creates a very challenging set of circumstances for the TPA as the workload regarding completing this requirement falls back into your lap. It was for this reason we developed our solution to:
One of our main goals for TPA clients is to ensure you aren’t blamed for not completing the reporting when in reality you control only a portion of the data for this entire requirement.